Skip Navigation



Home » Drug Information » FDA Approved Drugs » 1998
Medical Areas: Gastroenterology | Family Medicine

View By:YearCompanyConditionsTherapeutic AreasDrug Names

Zantac 75 Efferdose

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: GlaxoSmithKline
Approval Status: Approved March 1998
Treatment Area: heartburn

General Information

Zantac 75 Efferdose has been approved for the treatment of heartburn. It is the first over-the-counter effervescent H2 antagonist.